Skip to content

A clinical trial to study the effects of drugs i.e. levobupivacaine alone and dexmedetomidine added to levobupivacaine for caudal block in children undergoing below umbilical surgeries.

Evaluation of dexmedetomidine as an adjuvant to levobupivacaine for caudal analgesia in children undergoing elective infraumbilical surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/07/014769
Enrollment
80
Registered
2018-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients undergoing infraumbilical surgeries.

Interventions

Intervention1: Levobupivacaine with dexmedetomidine: 0.25% levobupivacaine in the dose of 1ml/kg body weight with dexmedetomidine 1 μg/kg in 0.5 ml normal saline. The drug will be administered only

Sponsors

AMARJEET KAUR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA grade 1 & 2 patients. 2.patients scheduled for infraumbilical surgeries.

Exclusion criteria

Exclusion criteria: 1.Parental refusal. 2.History of developmental delay or mental retardation. 3.Children with known allergy to any of the study drugs. 4.Children with coagulation disorders. 5.children with coexisting Medical illness.6.Preexisting neurological diseases. 7.Anatomical abnormalities of sacrum and spine. 8.Any signs of infection at the site of proposed caudal block.

Design outcomes

Primary

MeasureTime frame
Duration of Analgesia Timepoint: In first 24 hours of post operative period.

Secondary

MeasureTime frame
1.Pain intensity 2.Level of sedationTimepoint: In post operative period,at 0,2,4,6,8,12,16,24 hour intervals.

Countries

India

Contacts

Public ContactDr Amanjot Singh

G.G.S.Medical College and Hospital, Faridkot

amanjotrajpal@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026